Legal & General Group’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
Other funds holding STRO
KCM
Legal & General Group's STRO Position: Q3 2026 in Review
Legal & General Group reduced its Sutro Biopharma (STRO) stake by 7.4% in Q3 2026, selling an estimated $5.65K and leaving 3,206 shares worth $51.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2719.
Legal & General Group first reported a position in STRO in Q4 2018 and has held it in 28 quarters since. The position peaked at $213K in Q3 2021. 107 funds tracked by Wall St. Rank hold STRO as of Q3 2026.
- Legal & General Group held 3,206 shares of Sutro Biopharma worth $51.6K as of Q3 2026.
- Legal & General Group sold 256 Sutro Biopharma shares in Q3 2026, an estimated $5.65K.
- Sutro Biopharma made up ﹤0.01% of Legal & General Group's portfolio in Q3 2026, its #2719 holding.
- Legal & General Group first reported a position in Sutro Biopharma in Q4 2018 and has held it in 28 quarters since.
- Legal & General Group's Sutro Biopharma position peaked at $213K in Q3 2021.
- 107 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2026.
Based on Legal & General Group's 13F filing for Q3 2026, filed 16 Nov 2026.